Prescription Drug Pricing
House Oversight and Government Reform Committee
Developments in the Prescription Drug Market: Oversight
Thursday February 4, 2016 9:00 a.m.
Room: 2154 Rayburn Bldg.
Ms. Janet Woodcock, Director, Food and Drug Administration - Center for Drug Evaluation and Research
Mr. Howard Schiller, Interim CEO, Valeant Pharmaceuticals International, Inc.
Mr. Martin Shkreli, Former CEO, Turing Pharmaceuticals LLC
Ms. Nancy Retzlaff, Chief Commercial Officer, Turing Pharmaceuticals LLC
Mr. Mark Merritt, President and CEO, Pharmaceutical Care Management Association